Literature DB >> 17535022

Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery.

A K Bhatnagar1, D Kondziolka, L Dade Lunsford, John C Flickinger.   

Abstract

The purpose of this study was to devise a new recursive partitioning analysis (RPA) of patients with four or more intracranial metastases treated with a single radiosurgery procedure to identify a class of patients with extended survival. 205 patients underwent Gamma Knife radiosurgery for four or more intracranial metastases (median = 5, range 4-18) during one session. The median total treatment volume was 6.8 cc (range 0.6-51.0 cc). Radiosurgery was used as sole management (17% of patients), or in combination with WB-RT (46%), or after failure of WB-RT (38%). The median marginal radiosurgery dose was 16 Gy (range 12-20 Gy). RPA assessed the effects of age, Karnofsky >70, extracranial disease, visceral metastases, number of metastases, total treatment volume, history of breast and melanoma primaries on survival. The median overall survival after radiosurgery for all patients was 8 months. RPA identified a favorable subgroup of 78 patients (43% of the series) with a total treatment volume <7 cc and < 7 brain metastases (Class 1), with a median survival of 13 months. This subgroup's survival was significantly better (p <0.00005) than the remaining patients (Class 2) (n=111) with a median survival of 6 months. In conclusion, RPA of multiple brain metastasis patients identified 2 distinct cohorts of patients. Class 1 patients have a total treatment volume <7 cc and < 7 metastases (4-6) with favorable survival after Radiosurgery and Class 2 patients have a total treatment volume > or = 7 cc and/or > or = 7 metastases and have a significantly poorer survival.

Entities:  

Mesh:

Year:  2007        PMID: 17535022     DOI: 10.1177/153303460700600301

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  10 in total

1.  Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.

Authors:  Louis Burt Nabors; Jana Portnow; Mario Ammirati; Henry Brem; Paul Brown; Nicholas Butowski; Marc C Chamberlain; Lisa M DeAngelis; Robert A Fenstermaker; Allan Friedman; Mark R Gilbert; Jona Hattangadi-Gluth; Deneen Hesser; Matthias Holdhoff; Larry Junck; Ronald Lawson; Jay S Loeffler; Paul L Moots; Maciej M Mrugala; Herbert B Newton; Jeffrey J Raizer; Lawrence Recht; Nicole Shonka; Dennis C Shrieve; Allen K Sills; Lode J Swinnen; David Tran; Nam Tran; Frank D Vrionis; Patrick Yung Wen; Nicole R McMillian; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2014-11       Impact factor: 11.908

Review 2.  Radiosurgery for metastatic brain tumors.

Authors:  Toru Serizawa
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

3.  Executive summary from American Radium Society's appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases.

Authors:  Michael T Milano; Veronica L S Chiang; Scott G Soltys; Tony J C Wang; Simon S Lo; Alexandria Brackett; Seema Nagpal; Samuel Chao; Amit K Garg; Siavash Jabbari; Lia M Halasz; Melanie Hayden Gephart; Jonathan P S Knisely; Arjun Sahgal; Eric L Chang
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

4.  Current standards in the management of cerebral metastases.

Authors:  Pablo Goetz; Julius O Ebinu; David Roberge; Gelareh Zadeh
Journal:  Int J Surg Oncol       Date:  2011-11-10

5.  Metastatic melanoma: prognostic factors and survival in patients with brain metastases.

Authors:  E Frinton; D Tong; J Tan; G Read; V Kumar; S Kennedy; C Lim; R E Board
Journal:  J Neurooncol       Date:  2017-08-17       Impact factor: 4.130

6.  Retrospective study of 229 surgically treated patients with brain metastases: Prognostic factors, outcome and comparison of recursive partitioning analysis and diagnosis-specific graded prognostic assessment.

Authors:  Mirza Pojskic; Miriam H A Bopp; Markus Schymalla; Christopher Nimsky; Barbara Carl
Journal:  Surg Neurol Int       Date:  2017-10-24

7.  Presentation and outcome in cancer patients with extensive spread to the brain.

Authors:  Carsten Nieder; Adam Pawiniski; Astrid Dalhaug
Journal:  BMC Res Notes       Date:  2009-12-12

Review 8.  Prognostic indices for brain metastases--usefulness and challenges.

Authors:  Carsten Nieder; Minesh P Mehta
Journal:  Radiat Oncol       Date:  2009-03-04       Impact factor: 3.481

9.  Future directions in treatment of brain metastases.

Authors:  Igor J Barani; David A Larson; Mitchel S Berger
Journal:  Surg Neurol Int       Date:  2013-05-02

10.  Brain metastases from esophageal cancer: A case report.

Authors:  Shuai Qie; Yuge Ran; Huibin Yang; Guimin Cui; Miaoling Liu; Xiaojing Sun; Yuan Tian; Wenfan Sun; Nan Li; Chan Liu
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.